Children's Cancer Caring Center
» DNA
Published on Friday, October 19, 2012 by mcypen
Researchers discovered key mutations that may be responsible for medulloblastoma, the most common form of cancerous brain tumor in children, according to a new study, published in the journal Nature. The findings provide doctors and researchers with biomarkers that could be used to detect and treat the disease earlier, researchers said.
Medulloblastomas occur in th...
Published on Tuesday, October 2, 2012 by mcypen
Identifying large-scale chromosomal damage through a whole-genome scan can help doctors choose the best option for treatment of neuroblastoma in children. An international collaboration led by The Institute of Cancer Research, London, England, called for all children with neuroblastoma to undergo a whole-genome scan as a standard part of their treatment. The study was...
Published on Thursday, August 9, 2012 by mcypen
SALT LAKE CITY—A new study of the genetic makeup, or genome, of Ewing sarcoma, a rare cancer that strikes children, teenagers, and young adults, has produced multiple discoveries: a previously unknown sarcoma subtype, genetic factors related to long-term survival, and identification of a genetic change between the primary and metastatic stages of the disease that co...
Published on Sunday, April 1, 2012 by mcypen
A newly discovered genetic mutation is more common in teens and young adults than infants with a nerve tissue cancer called neuroblastoma.
The gene with the defect is called ATRX. While this defect was found in many teens and young adults with neuroblastoma, none of the infants with the disease who were tested had this genetic defect. This is important because babies...
Published on Wednesday, February 1, 2012 by mcypen
Chemotherapy is poison that happens to kill cancer cells faster than it kills healthy cells; that it wreaks havoc on the bodies of patients is unsurprising. But chemo may also affect their unborn children. According to a new study in PNAS, the offspring of mice treated with chemotherapy have higher rates of mutation, even though the offspring themselves were never exp...
Published on Wednesday, February 1, 2012 by mcypen
Scientists have made a medical breakthrough after discovering two genetic mutations responsible for up to 40% of brain cancer tumours in children.
Study researchers from the Research Institute of the McGill University Health Centre, believe that their discovery could change the way pediatric cancers are treated, especially glioblastoma, which is a deadly brain cancer...
A Message From Our CEO Donate Now
Facebook
Your generous donation can help us save the life of Demetrious and so many other children just like him. Click the link below to find out how you can receive a bracelet designed exclusively for the CCCC to show your support for the children--it's our way of saying thanks for caring.
